KELLY VASQUEZ GARCIA: Open Payments
NPI 1942901947 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 28 payments from 8 companies in 2025. Trend: 2023 $195 · 2024 $221 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $198 |
| Corcept Therapeutics | 9 | $186 |
| Novo Nordisk Inc | 7 | $148 |
| Boston Scientific Corporation | 1 | $58 |
| Hologic Sales and Service, LLC | 2 | $54 |
| Amgen Inc. | 3 | $50 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: Korlym, BREZTRI, Ozempic, WaveWriter Alpha Prime 16, FARXIGA, THINPREP 2000 PROCESSOR, REPATHA, GEMTESA.
Industry payments across CA — which companies pay providers there.
